Business:
Rare Muscle Disorders
Drug notes:
Also Clin2 myelofibrosis; KER-047 Clin2 iron deficiency anemia, Clin1 iron deficiency anemia in MDS & MF; KER-012 Clin1PAH; undisclosed Clin0 musculoskeletal conditions
About:
Keros Therapeutics is discovering and developing treatments for rare hematologic and musculoskeletal disorders. A wide range of disorders are linked to dysfunctional signaling of the transforming growth factor-beta (TGF-β). At Keros, they are using their protein engineering and drug development expertise to uncover targets within the TGF-β superfamily. By developing therapeutics that can intervene in this pathway, Keros aims to target pathways critical for the growth, repair and maintenance of blood cells and a number of tissues including bone, skeletal muscle, adipose and heart tissue.
Not seeing a current fit? Apply here for future op... Lexington, MA|8 days ago
Contract Senior Research Associate I - In Vivo Lexington, MA|33 days ago